Fixed Dose MMF vs Concentration Controlled MMF After Renal Transplantation
Status:
Completed
Trial end date:
2006-04-01
Target enrollment:
Participant gender:
Summary
Determine the value of a clinically feasible strategy of therapeutic drug monitoring compared
with fixed dosing in de novo MMF treated renal transplant recipients with respect to the
incidence of treatment failure.